Merck KGaA buys Chinese Firm

Merck KGaA says it has acquired Beijing Skywing Technology (Beijing), a leading supplier of cell-culture media products, related technical services, and bioreactors for the biopharmaceutical industry in China, for Rmb120 million ($18 million). The Chinese biopharmaceutical market is expected to grow 20%/year in the next several years, driven primarily by the local vaccine and antibody industries, Merck KGaA...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers